Dr. Fakhar Waqas

Postdoctoral Researcher | Project Leader “Host-directed Antiviral Compounds”
Contact
(0)511-220027-165fakhar.waqas@twincore.de

Publications

2024Respiratory research25 (1) : 369

Differential transcriptomic host responses in the early phase of viral and bacterial infections in human lung tissue explants ex vivo

Sohail A, Waqas F, Braubach P, Czichon L, Samir M, Iqbal A, de Araujo L, Pleschka S, Steinert M, Geffers R, Pessler F

2024Trends in endocrinology and metabolism: TEM35 (7) : 561-562

Aconitate decarboxylase (ACOD1) has found a disease

Waqas F, Chen C, Pessler F

2023Journal of translational medicine21 (1) : 776

Elevated phospholipids and acylcarnitines C4 and C5 in cerebrospinal fluid distinguish viral CNS infections from autoimmune neuroinflammation

Al-Mekhlafi A, Waqas F, Krueger M, Klawonn F, Akmatov M, Müller-Vahl K, Trebst C, Skripuletz T, Stangel M, Sühs K, Pessler F

Show all publications

Posts

The scientist Dr. Fangfang Chen characterised the molecule itaconic acid © TWINCORE / Grabowski

Cell protection, immunomodulation and virus inhibition by an endogenous substance

Previously unknown effects of citraconic acid described

Read more
The two scientists Fakhar Waqas (l.) and Frank Peßler in the laboratory

Cancer drug works against viruses 

TWINCORE researchers describe a mechanism that inhibits virus replication and protects cells from damage. Interestingly, a drug that has already been approved could prove useful in combating various viruses. 

Read more

Antiviral and anti-inflammatory

Double effect of the body's own signalling molecule itaconic acid described

Read more
Show all posts